Skip main navigation

Newsroom
Newsroom

Home > Newsroom > 2007 > Notice of Execution of Acquisition of the Company's Own Shares

Skip side navigation

Main contents starts here

June 26, 2007

Takeda Pharmaceutical Company Limited

Notice of Execution of Acquisition of the Company's Own Shares

OSAKA, Japan, June 26, 2007 --- Takeda Pharmaceutical Company Limited ("Takeda") announced today that it completed acquisition of its own shares in the market, which was resolved by its Board of Directors on May 18, 2007.

1. Class of shares acquired : Shares of common stock
2. Period of acquisition : From May 21, 2007 to June 22, 2007
3. Total number of shared acquired : 3,631,100 shares
4. Total value of acquisition : Yen 28,562,150,000
5. Method of acquisition : Purchased on the Tokyo Stock Exchange

(Reference)
Resolution of the Board of Directors on May 18, 2007
1. Class of shares to be acquired : Shares of common stock
2. Number of shares to be acquired : Up to 10 million shares
(equivalent to 1.12% of a total of issued shares)
3. Total value of shares to be acquired : Up to 75 billion Yen
4. Schedule of acquisition : From May 21, 2007 to June 22, 2007

# # #

Page Top